Researchers at the University of Adelaide are spearheading a new direction in prostate cancer research, with the potential for new treatments of the disease.
The researchers have just begun new studies that they hope will overcome a major problem that limits current treatments for metastatic prostate cancer, and improve men’s chances of surviving.
Prostate cancer is the most common cancer diagnosed in Australian men and the second most common cause of cancer-related death in men.
Until now, researchers around the world have focused their efforts on developing new drugs that block the actions of male hormones, called androgens, in prostate cancer cells, but most patients become resistant to these treatments. Research at the University of Adelaide is part of a worldwide effort to find a new way of destroying the resistant cancer cells.
“This global project is a completely new direction for prostate cancer research, and we are very excited to be a major part of it,” says Professor Wayne Tilley, Head of the University of Adelaide’s Dame Roma Mitchell Cancer Research Laboratories. Learn more